Daphne Karydas, Director: Mineralys Therapeutics MLYS Planned sale · Filed 03/31

Trade details

Type: Planned sale notice
Stock: Mineralys Therapeutics MLYS
Person: Daphne KarydasDirector
Planned sale date: 26/03/31
Filed: 26/03/31

$75K to be sold

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Daphne Karydas's recent trades

Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$85.7K
3,000 sh
$85.7K
Filed 09/15
Traded 09/15
Daphne KarydasDirector
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 06/17
Traded 06/17
Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 06/17
Traded 06/17
Daphne KarydasDirector
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 04/02
Traded 03/31
Daphne KarydasDirector
SellMineralys Therapeutics
Sell
Mineralys Therapeutics
MLYS
$463.4K
10,115 sh
$463.4K
Filed 25/11/13
Traded 25/11/13